Immunoexpression of the GCDFP-۱۵ Marker in Different Grades of Breast Carcinoma

سال انتشار: 1402
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 261

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:

شناسه ملی سند علمی:

JR_IJP-18-1_008

تاریخ نمایه سازی: 26 اردیبهشت 1402

چکیده مقاله:

Background & Objective: During the last decade, biological markers of breast cancer have been considered to predict the degree of histology, behavior, and extent of tumor invasion and the possibility of lymph node involvement. The aim of this study was to evaluate the expression of GCDFP-۱۵ in different grades of invasive ductal carcinoma, as the most common type of breast cancer.Methods: In this retrospective study, paraffin blocks of tumors of ۶۰ breast cancer patients registered in the histopathology laboratory of Imam Khomeini Hospital in Ahvaz between ۲۰۱۹ and ۲۰۲۰ were reviewed. Information on grade, invasion, stage and lymph node involvement was extracted from the pathology reports and immunohistochemical staining for GCDFP-۱۵ was performed. Data were analyzed by SPSS ۲۲.Results: GCDFP-۱۵ marker expression was observed in ۲۰ out of ۶۰ breast cancer patients (۳۳.۳%). GCDFP-۱۵ staining intensity was weak in ۷ cases (۳۵%), moderate in ۸ cases (۴۰%), and strong in ۵ cases (۲۵%). The patient's age and sex showed no significant relationship with the expression of GCDFP-۱۵ and intensity of staining. Expression of the GCDFP-۱۵ marker was correlated significantly with tumor grade, stage, and vascular invasion (P<۰.۰۵)) and its expression was higher in tumors with a lower grade, less depth of invasion, and no vascular invasion but unrelated to perineural invasion, lymph node involvement, and tumor size. The intensity of staining for GCDFP-۱۵ showed significant relationship with the tumor grade (P<۰.۰۰۰۱) but unrelated to the other factors.Conclusion: GCDFP-۱۵ marker may be significantly associated with tumor grade, depth of invasion, and vascular invasion, thus can be used as a prognostic marker.

نویسندگان

Faeze Shirian

Department of Pathology, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran

Parvin Kheradmand

Cancer Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran

Nastaran Ranjbari

Department of Pathology, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran

Hodjatollah Shahbazian

Cancer Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran

Seyed Mahmoud Latifi

Department of Clinical Oncology and Radiotherapy, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran

مراجع و منابع این مقاله:

لیست زیر مراجع و منابع استفاده شده در این مقاله را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود مقاله لینک شده اند :
  • Łukasiewicz S, Czeczelewski M, Forma A, Baj J, Sitarz R, ...
  • Fiel MI, Cernaianu G, Burstein DE, Batheja N. Value of ...
  • Celis JE, Gromova I, Gromov P, Moreira JM, Cabezón T, ...
  • Luo MH, Huang YH, Ni YB, Tsang JY, Chan SK, ...
  • Hall RE, Clements JA, Birrell SN, Tilley WD. Prostate-specific antigen ...
  • نمایش کامل مراجع